News
Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own ...
HHS Sec. RFK Jr. says Dr. Anthony Fauci is likely liable for the origins of the COVID-19 pandemic, calling for a nationwide ...
2d
Investor's Business Daily on MSNBioNTech ADR Earns Relative Strength Rating UpgradeBioNTech ADR BNTX saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 68 to 73. Please ...
Big Pharmas like Eli Lilly, Sanofi and Novartis headed back to the dealmakers table multiple times, with 32 total deals ...
IMM2510, a differentiated PD-L1xVEGF bispecific antibody with upcoming data in H2 2025. Click to read why TIL is a Hold.
The revamped and “more anti-vax skewed ACIP committee” at the CDC “has a bone to pick with mRNA vaccines,” according to ...
The FDA has approved its requested updated versions of expanded warning labels for COVID-19 vaccines. As Healio previously ...
Global manufacturers are constantly revamping their network of plants. Surviving over the long term for a factory—especially ...
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $135.18, with a high estimate of $155.00 and a low estimate of $110.00. Highlighting a 3.58% ...
Treating types of cancer with CAR T-cell therapy is expensive and inconvenient, but a streamlined approach that creates the ...
The discussion concluded with the implications of BioNTech’s proposed acquisition of CureVac (2). While some speculate the move is related to an ongoing patent dispute, the panel suggested the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results